Evidence map›Paper›PMID 32251167›Full record

ArticleCornea2020

Ocular Clinical Signs and Diagnostic Tests Most Compatible With Keratoconjunctivitis Sicca: A Latent Class Approach.

John A Gonzales, Stephen C Shiboski, Vatinee Y Bunya, Esen K Akpek, Jennifer Rose-Nussbaumer, Gerami D Seitzman, Lindsey A Criswell, Caroline H Shiboski, Thomas M Lietman

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Cornea, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Diagnostic methods for managing dry eyes.World journal of methodology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Clinical relationship between dry eye disease and uveitis: a scoping review.Journal of ophthalmic inflammation and infection · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Mouse Models of Sjögren's Syndrome with Ocular Surface Disease.International journal of molecular sciences · 2020
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

John A GonzalesFrancis I. Proctor Foundation, University of California San Francisco, San Francisco, CA.
Stephen C ShiboskiDepartment of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA.
Vatinee Y BunyaDepartment of Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA.
Esen K AkpekOcular Surface Diseases and Dry Eye Clinic, The Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD.
Jennifer Rose-NussbaumerDepartment of Ophthalmology, Kaiser Permanente, Redwood City, CA.
Gerami D SeitzmanFrancis I. Proctor Foundation, University of California San Francisco, San Francisco, CA.
Lindsey A CriswellDepartments of Medicine; and.
Caroline H ShiboskiOrofocial Sciences, School of Dentistry, University of California San Francisco, San Francisco, CA.
Thomas M LietmanFrancis I. Proctor Foundation, University of California San Francisco, San Francisco, CA.
San Francisco Foundation · USJohns Hopkins University · USKaiser Permanente Redwood City Medical Center · USUniversity of California, San Francisco · USUniversity of Pennsylvania · US

Funding

Rapid-Prototyping and Design CoreP30EY002162 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ULLIAN, ERIK M · 1985 to 2024
$16.8M
Sjögren's International Collaborative Clinical Alliance Next Generation Studies (SICCA-NextGen)U01DE028891 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SHIBOSKI, CAROLINE HELENE · 2020 to 2024
$4.0M
Developing new methods for early detection of Sjogren's syndromeR01EY026972 · NEI · UNIVERSITY OF PENNSYLVANIA · PI BUNYA, VATINEE Y · 2016 to 2020
$2.0M
Non-Sjogren's Syndrome-and Sjogren's Syndrome-related Keratoconjunctivitis SICCA: A Spectrum of Inflammatory Dry EyeK23EY026998 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GONZALES, JOHN ALEXANDER · 2016 to 2020
$1.3M
Oral Health Outcomes in Pediatric Transplant RecipientsR03DE014939 · NIDCR · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI SHIBOSKI, CAROLINE HELENE · 2003 to 2004
$152k
NEI NIH HHS K23 EY026998NEI NIH HHS P30 EY002162NEI NIH HHS R01 EY026972NHLBI NIH HHS HHSN268201300057CNIDCR NIH HHS R03 DE014939NIDCR NIH HHS U01 DE028891
6 · The paper itself

Abstract

purposeTo evaluate the ocular signs and tests for keratoconjunctivitis sicca (KCS) in the absence of a gold standard.

methodsCross-sectional study of participants from the Sjögren's International Collaborative Clinical Alliance (SICCA) registry. Participants had oral/ocular/rheumatologic examinations, blood/saliva samples collected, and salivary gland biopsy. Latent class analysis (LCA) identified clusters of patients based on 3 to 4 predictor variables relating to signs or tests of KCS. The resulting model-based "gold standard" classification formed the basis for estimated sensitivity and specificity associated with these predictors.

resultsA total of 3514 participants were enrolled into SICCA, with 52.9% classified as SS. LCA revealed a best-fit model with 2 groups. For the gold standard-positive group, an abnormal tear breakup time, ocular staining score (OSS), and Schirmer I had a sensitivity of 99.5%, 91.0%, and 47.4%, respectively. For the gold standard-negative group, an abnormal tear breakup time, OSS, and Schirmer I had a specificity of 32.0%, 84.0%, and 88.5%, respectively. OSS components (fluorescein and lissamine staining), exhibited a sensitivity of 82.6% and 90.5%, respectively, in the gold standard-positive group, whereas these signs in the gold standard-negative group had a specificity of 88.8% and 73.0%, respectively.

conclusionsOSS and its components (fluorescein and lissamine staining) differentiated 2 groups from each other better than other KCS parameters and had relatively high sensitivity and specificity.

Indexed as

RegistriesConjunctivaCross-Sectional StudiesFemaleHumansKeratoconjunctivitis SiccaMaleTearsYoung Adult

Identifiers

PMID32251167
PMCPMC7410365
OpenAlexW3014683961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.